The Single Largest Integrated AI-Ready Molecule-to-Market Data Platform
Unified Intelligence Across the Healthcare Ecosystem
Our platform brings together diverse, high-value healthcare and life sciences data into a seamless, AI-ready knowledge graph.
From molecular research and clinical trials to regulatory intelligence, market access, commercialization, and real-world evidence — we connect every critical data layer.
By eliminating data silos, we empower organizations to:
This is not just data aggregation — it’s deep contextual linkage designed for AI-driven decision-making.
Unified Intelligence Across the Healthcare Ecosystem
Our platform brings together diverse, high-value healthcare and life sciences data into a seamless, AI-ready knowledge graph.
From molecular research and clinical trials to regulatory intelligence, market access, commercialization, and real-world evidence — we connect every critical data layer.
By eliminating data silos, we empower organizations to:
Accelerate R&D decisions
Improve clinical strategy
Optimize regulatory pathways
Strengthen commercialization performance
Unlock real-world patient insights
This is not just data aggregation — it’s deep contextual linkage designed for AI-driven decision-making.
KEY PERFORMANCE INDICATORS (KPIs)
1
Data Volume
Millions of structured records spanning molecules, targets, trials, regulatory filings, products, pricing, patents, market performance, and patient pathways.
2
Data Completeness
End-to-end lifecycle coverage — Discovery → Clinical → Regulatory → Launch → Market Access → Real-World Outcomes.
3
Near Real-Time Updates
Continuous data ingestion pipelines ensure minimal lag between data generation and availability.
4
Data Quality Assurance
Subject Matter Expert (SME) review
AI-powered data validation
Cross-source reconciliation
Automated anomaly detection
5
Interoperability
Standardized data models aligned to global healthcare ontologies, ensuring seamless system integration.
Unified Intelligence Across the Healthcare Ecosystem
Our platform brings together diverse, high-value healthcare and life sciences data into a seamless, AI-ready knowledge graph.
From molecular research and clinical trials to regulatory intelligence, market access, commercialization, and real-world evidence — we connect every critical data layer.
By eliminating data silos, we empower organizations to:
This is not just data aggregation — it’s deep contextual linkage designed for AI-driven decision-making.
KEY PERFORMANCE INDICATORS (KPIs)
Data Volume
Millions of structured records spanning molecules, targets, trials, regulatory filings, products, pricing, patents, market performance, and patient pathways.
Data Completeness
End-to-end lifecycle coverage — Discovery → Clinical → Regulatory → Launch → Market Access → Real-World Outcomes.
Near Real-Time Updates
Continuous data ingestion pipelines ensure minimal lag between data generation and availability.
Data Quality Assurance
Subject Matter Expert (SME) review
AI-powered data validation
Cross-source reconciliation
Automated anomaly detection
Unified Intelligence Across the Healthcare Ecosystem
Our platform brings together diverse, high-value healthcare and life sciences data into a seamless, AI-ready knowledge graph.
From molecular research and clinical trials to regulatory intelligence, market access, commercialization, and real-world evidence — we connect every critical data layer.
By eliminating data silos, we empower organizations to:
Accelerate R&D decisions
Improve clinical strategy
Optimize regulatory pathways
Strengthen commercialization performance
Unlock real-world patient insights
This is not just data aggregation — it’s deep contextual linkage designed for AI-driven decision-making.
KEY PERFORMANCE INDICATORS (KPIs)
1
Data Volume
Millions of structured records spanning molecules, targets, trials, regulatory filings, products, pricing, patents, market performance, and patient pathways.
2
Data Completeness
End-to-end lifecycle coverage — Discovery → Clinical → Regulatory → Launch → Market Access → Real-World Outcomes.
3
Near Real-Time Updates
Continuous data ingestion pipelines ensure minimal lag between data generation and availability.
4
Data Quality Assurance
Subject Matter Expert (SME) review
AI-powered data validation
Cross-source reconciliation
Automated anomaly detection
5
Interoperability
Standardized data models aligned to global healthcare ontologies, ensuring seamless system integration.
Foundational Scale
500M+
Interconnected biological, clinical, and regulatory data points powering enterprise intelligence.
Data Velocity
24/7
Continuous data ingestion spanning from early genomic discovery to post-market regulations
Evidence Traceability
100%
Fully source-verified data relationships structured specifically for enterprise AI reasoning
Data Reliability
99.9%
Guaranteed data accuracy via automated validation and strict structural integrity checks
Unifying the Drug Development Data Lifecycle
We transform raw, global healthcare data into strategic assets. By mapping millions of disconnected biological, clinical, and regulatory data points into a single Knowledge Graph, we create an AI-ready foundation. This deep, structured linkage allows life sciences teams to seamlessly navigate from early discovery to market access.
Mapping 15,000+ disease taxonomies by linking specific genomic concepts, biomarkers, and mutations directly to primary therapeutic areas
Ingesting global literature and patents to map gene-disease-drug interactions, validating mechanisms of action and identifying novel IP pathways
Storing deep structural drug data by classifying active moieties, substance subclasses, precise ingredients, and biological pathways
Mapping 450,000+ global trial protocols to structure sponsor entities, investigator site performance, and patient enrollment metrics
Detailing precise clinical contexts, including indication populations, disease stages, treatment lines (1L, 2L, 3L), and evolving therapeutic modalities
Connecting actions across 60+ global agencies to structure drug registrations, dosage forms, and exact FDA/EMA approval timelines
Tracking commercial viability through Health Technology Assessment (HTA) outcomes, global pricing evaluations, and regional reimbursement precedents
Ingesting continuous Real-World Evidence (RWE) to track post-market safety signals, adverse events, and shifting competitive pipelines
Molecular & Target Intelligence
Preclinical Insights
Integrated in-vitro, in-vivo, toxicology, pharmacology, and biomarker datasets directly linked to compounds, targets, and disease models for informed development decisions.
Clinical Trial Intelligence
Study design, endpoints, sponsors, investigators, enrollment status, results, and trial outcomes connected to molecules, indications, and competitive landscapes.
Regulatory & Approval Data
INDs, NDAs, BLAs, approvals, designations, submissions, and labeling updates mapped across major markets to monitor regulatory pathways and milestone progress.
Commercial & Market Intelligence
Pricing, reimbursement, sales performance, forecasts, competitive positioning, and lifecycle strategies linked to products, companies, and therapeutic areas.
Epidemiology & Patient Data
Incidence, prevalence, disease burden, treatment patterns, patient segmentation, and unmet needs structured to support strategic and clinical planning.
Manufacturing & Supply Chain
Manufacturing sites, supply networks, batch data, CMO relationships, and global distribution linkages for operational risk management and continuity planning.
Publications & Scientific Evidence
Peer-reviewed literature, abstracts, citations, KOL insights, and conference data seamlessly connected to molecules, trials, and sponsoring organizations.
DATA DELIVERY & ACCESS
Flexible, Scalable & AI-Ready Delivery
We provide secure, enterprise-grade access through:
Our platform is designed to plug directly into your digital ecosystem.
Turning Complex Data into Strategic Advantage
Our integrated intelligence helps clients:
Accelerate early-stage innovation by replacing manual literature review with automated, AI-driven target discovery. Instantly cross-reference global genomics, patents, and scientific publications to validate biological rationales.
Identify Novel Targets: Uncover hidden gene-disease-drug connections
De-Risk Pipelines: Evaluate early safety signals and pathophysiology
Reduce manual pre-clinical review by up to 80%.
Eliminate costly trial delays by transforming historical clinical data into predictive trial intelligence. Optimize protocol designs and accurately rank global investigator sites based on past performance and real-world data..
Optimize Site Selection: Rank top-performing global investigators
Accelerate Enrollment: Identify precise patient subgroups and biomarkers
Reduce clinical trial start-up time by 50–70%
Streamline complex global submissions by instantly extracting exact claims and precedents. Our AI assistants seamlessly navigate disjointed FDA and EMA databases to provide source-verified, traceable intelligence.
Accelerate Submissions: Extract exact precedents and approval timelines
Ensure Compliance: Track changing global regulatory landscapes
Save thousands of hours in manual dossier preparation
Proactively protect patient safety and pipeline viability. Use continuous AI monitoring to ingest real-world evidence (RWE), clinical registries, and literature to detect early adverse events before they escalate.
Monitor Safety Signals: Track AEs across real-world data sources
Ensure Drug Efficacy: Cross-reference post-market registries globally
Mitigate risk of costly late-stage clinical holds
How data can help client
Our integrated intelligence helps clients: